Literature DB >> 10329443

Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.

H Lu1, M Dhanabal, R Volk, M J Waterman, R Ramchandran, B Knebelmann, M Segal, V P Sukhatme.   

Abstract

Angiostatin which contains the first four kringle domains of plasminogen has been documented to be a potent inhibitor of angiogenesis. More recently, another kringle structure within plasminogen but outside angiostatin, known as kringle 5 (K5), was found to inhibit endothelial cell proliferation and migration. Here, we report the cloning and expression of mouse kringle 5 (rK5) in a bacterial expression system. The protein was purified to homogeneity using a Ni-NTA column. rK5 inhibited both proliferation and migration of endothelial cells with ED50's of 10 nM and < 500 nM, respectively. In addition, we show for the first time that rK5 causes cell cycle arrest and apoptosis, shedding further insight into rK5's mechanism of action. Finally, we show that these actions are endothelial cell specific. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329443     DOI: 10.1006/bbrc.1999.0612

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.

Authors:  Ji Jin; Kevin K Zhou; Kyoungmin Park; Yang Hu; Xun Xu; Zhi Zheng; Puneet Tyagi; Uday B Kompella; Jian-xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-05       Impact factor: 4.799

2.  Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop.

Authors:  Lei Li; Ya-Chao Yao; Xiao-Qiong Gu; Di Che; Cai-Qi Ma; Zhi-Yu Dai; Cen Li; Ti Zhou; Wei-Bin Cai; Zhong-Han Yang; Xia Yang; Guo-Quan Gao
Journal:  J Biol Chem       Date:  2014-10-08       Impact factor: 5.157

Review 3.  New molecular targets in angiogenic vessels of glioblastoma tumours.

Authors:  Joshua C Anderson; Braden C McFarland; Candece L Gladson
Journal:  Expert Rev Mol Med       Date:  2008-08-07       Impact factor: 5.600

4.  Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: sensitization by radiation and requirement for GRP78 and LRP1.

Authors:  Braden C McFarland; Jerry Stewart; Amal Hamza; Robert Nordal; Donald J Davidson; Jack Henkin; Candece L Gladson
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

5.  Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model.

Authors:  Ho-Jeong Lee; Hyun-Kyung Yu; John N Papadopoulos; Seung Wook Kim; Junqin He; Yong-Keun Park; Yeup Yoon; Jang-Seong Kim; Sun Jin Kim
Journal:  Neoplasia       Date:  2012-04       Impact factor: 5.715

6.  Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.

Authors:  Weiwei Jiang; Guanghui Jin; Dingyuan Ma; Feng Wang; Tong Fu; Xiao Chen; Xiwen Chen; Kunzhi Jia; Faiz M M T Marikar; Zichun Hua
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

7.  A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy.

Authors:  Thomas Neill; Aastha Kapoor; Christopher Xie; Simone Buraschi; Renato V Iozzo
Journal:  Matrix Biol       Date:  2021-04-07       Impact factor: 10.447

8.  Voltage-Dependent Anion Channel-1, a Possible Ligand of Plasminogen Kringle 5.

Authors:  Yin-Ku Liang; Liu-Jiao Bian
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

9.  Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.

Authors:  Min Zhang; Rui Guo; Shuo Shi; Yin Miao; Yifan Zhang; Biao Li
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

10.  Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3).

Authors:  Carolyn J MacMillan; Carolyn D Doucette; Jordan Warford; Suzanne J Furlong; David W Hoskin; Alexander S Easton
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.